Clinical Trial Update: Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial to test adding ZEN003694 to the Cetuximab plus Encorafenib regimen for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Encorafenib (encorafenib)
• ZEN003694

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Colorectal Adenocarcinoma, Recurrent Colorectal Adenocarcinoma | Phase 1 | Status: RECRUITING